AI Article Synopsis
- - A new CT imaging agent made from bismuth was developed using a straightforward synthesis method.
- - Researchers tested the agent for stability, toxicity, and performance in CT imaging.
- - In vivo imaging was conducted with various doses, and the effectiveness of the 1.2 mmol/kg dose was compared to the established CT agent, iopamidol, at the same dose.
Article Abstract
A new bismuth-based CT agent was synthesized through a facile synthesis strategy. The in vitro stability, toxicity and CT performance were evaluated. The in vivo imaging performance was investigated using three different doses (0.5, 1.2 and 5 mmol/kg) and the result obtained at 1.2 mmol/kg was compared with the clinically approved CT agent iopamidol at the same dosage.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556142 | PMC |
| http://dx.doi.org/10.1038/s41598-023-43031-y | DOI Listing |
Publication Analysis
Top Keywords
bi-hpdo3a novel
4
novel contrast
4
contrast agent
4
agent x-ray
4
x-ray computed
4
computed tomography
4
tomography bismuth-based
4
bismuth-based agent
4
agent synthesized
4
synthesized facile
4
Similar Publications
Bi-HPDO3A as a novel contrast agent for X-ray computed tomography.
Sci Rep
October 2023
Department of Molecular Biotechnology and Health Sciences, Molecular Imaging Centre, University of Torino, Via Nizza 52, 10126, Turin, Italy.
Article Synopsis
- - A new CT imaging agent made from bismuth was developed using a straightforward synthesis method.
- - Researchers tested the agent for stability, toxicity, and performance in CT imaging.
- - In vivo imaging was conducted with various doses, and the effectiveness of the 1.2 mmol/kg dose was compared to the established CT agent, iopamidol, at the same dose.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!